Read full disclaimer A research blend of three compounds co-formulated in one 70mg lyophilised vial: GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg), supplied as a reference material for laboratory research
Frazier, Ph.D., and Rabindra Tirouvanziam, Ph.D
It has more damage to address, and healing takes longer
The complete dosing math at 10 mg/mL Once your 30 mg vial is reconstituted with 3 mL of bacteriostatic water, every dose becomes a simple calculation
Some studies have demonstrated that many drugs inhibit ferroptosis and protect liver steatosis or carcinogenesis
The following dosing protocol for healing with TB-500 is not supported by any studies published thus far, but it can serve as a starting point for researchers, who are advised to begin with still lower doses and titrate upward approaching this protocol: Daily Dose: 2mg, administered subcutaneously Frequency: Daily subcutaneous injections Study Duration: 15 days Notes: Researchers need three vials of TB-500 10mg to complete this protocol